theophylline has been researched along with Cystic Fibrosis in 46 studies
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The sputum pharmacokinetics and clinical efficacy of ciprofloxacin in lower respiratory tract infections is reviewed." | 10.16 | Clinical efficacy of ciprofloxacin in lower respiratory tract infections. ( Pedersen, SS, 1989) |
| "The effect of theophylline (T) was studied in 12 children with cystic fibrosis (CF) (seven males and five females) aged 7 to 17 yr (mean, 11." | 9.07 | Effect of theophylline on lung function tests, sleep quality, and nighttime SaO2 in children with cystic fibrosis. ( Avital, A; Chernick, V; Holbrow, J; Kryger, M; Sanchez, I, 1991) |
| "Most patients with cystic fibrosis (CF) eventually develop chronic obstructive pulmonary disease and theoretically could benefit from theophylline therapy." | 9.06 | Bronchodilation from intravenous theophylline in patients with cystic fibrosis: results of a blinded placebo-controlled crossover clinical trial. ( Canafax, DM; Cipolle, RJ; Le, CT; Pan, SH; Uden, DL; Warwick, WJ, 1989) |
| "A study was designed to evaluate the reproducibility of right and left ventricular ejection fraction measurements (RVEF, LVEF) by equilibrium radionuclide angiography in cystic fibrosis (CF) and to determine the effect of the acute administration of aminophylline on RVEF and LVEF in this disease." | 9.05 | Radionuclide assessment of cardiac performance in cystic fibrosis. Reproducibility and effect of theophylline on cardiac function. ( Canny, GJ; de Souza, ME; Gilday, DL; Newth, CJ, 1984) |
| " The serum protein binding of theophylline was studied in 28 asthmatics and 11 patients with cystic fibrosis (CF) who were receiving the drug regularly." | 7.68 | Variability of the serum protein binding of theophylline in patients with asthma and cystic fibrosis. ( Blanchard, J; Harvey, S; Morgan, WJ, 1992) |
| "Theophylline levels in stimulated and unstimulated mixed saliva were compared with total and free (unbound) serum theophylline levels in 11 outpatients with cystic fibrosis (CF) who were using theophylline regularly." | 7.68 | Relationship between serum and saliva theophylline levels in patients with cystic fibrosis. ( Blanchard, J; Harvey, S; Morgan, WJ, 1992) |
| "Multiple aspects of lung function were measured in 17 cystic fibrosis (CF) patients on four occasions: without therapy (0); with oral theophylline medication (Th); after inhalation of salbutamol (beta 2); and with combined medication (Th + beta 2)." | 7.67 | Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathomimetics. ( Eber, E; Oberwaldner, B; Zach, MS, 1988) |
| "The elimination of theophylline after intravenous aminophylline bolus and the absorption of a sustained-release oral theophylline preparation (Theo-Dur) were studied in ten patients with cystic fibrosis (C." | 7.66 | Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis. ( Brooks, JG; Schwartz, RH; Valet, SB, 1983) |
| "The disposition of intravenously and orally administered theophylline was compared in 10 patients with cystic fibrosis (CF) and 10 healthy volunteers." | 7.66 | Theophylline disposition in cystic fibrosis. ( Isles, A; Levison, H; MacLeod, S; Spino, M; Tabachnik, E; Thiessen, J, 1983) |
| "The sputum pharmacokinetics and clinical efficacy of ciprofloxacin in lower respiratory tract infections is reviewed." | 6.16 | Clinical efficacy of ciprofloxacin in lower respiratory tract infections. ( Pedersen, SS, 1989) |
| "The effect of theophylline (T) was studied in 12 children with cystic fibrosis (CF) (seven males and five females) aged 7 to 17 yr (mean, 11." | 5.07 | Effect of theophylline on lung function tests, sleep quality, and nighttime SaO2 in children with cystic fibrosis. ( Avital, A; Chernick, V; Holbrow, J; Kryger, M; Sanchez, I, 1991) |
| "Most patients with cystic fibrosis (CF) eventually develop chronic obstructive pulmonary disease and theoretically could benefit from theophylline therapy." | 5.06 | Bronchodilation from intravenous theophylline in patients with cystic fibrosis: results of a blinded placebo-controlled crossover clinical trial. ( Canafax, DM; Cipolle, RJ; Le, CT; Pan, SH; Uden, DL; Warwick, WJ, 1989) |
| "A study was designed to evaluate the reproducibility of right and left ventricular ejection fraction measurements (RVEF, LVEF) by equilibrium radionuclide angiography in cystic fibrosis (CF) and to determine the effect of the acute administration of aminophylline on RVEF and LVEF in this disease." | 5.05 | Radionuclide assessment of cardiac performance in cystic fibrosis. Reproducibility and effect of theophylline on cardiac function. ( Canny, GJ; de Souza, ME; Gilday, DL; Newth, CJ, 1984) |
| "This study examined the effect of aerosolized isoproterenol and oral theophylline on pulmonary function in cystic fibrosis (CF) to determine how often these drugs are beneficial and whether there is a correlation between response to isoproterenol and response to oral theophylline." | 5.04 | The paradoxical effect of adrenergic and methylxanthine drugs in cystic fibrosis. ( Bamman, J; Bierman, CW; Kanarek, P; Shapiro, GG, 1976) |
| " This review focuses on advances and controversies in the therapy of asthma, including issues regarding medications such as inhaled beta 2-agonists, inhaled corticosteroids, cromolyn sodium, and theophylline." | 4.78 | Advances in respiratory therapeutics in children. ( Reisman, JJ, 1993) |
| "Bicycle ergospirometry was performed on 14 patients with cystic fibrosis (CF), for evaluating the effects of salbutamol and theophylline on the ventilatory response to exercise." | 3.68 | Increased physiological dead space during exercise after bronchodilation in cystic fibrosis. ( Friedrichs, F; Heimann, G; Kusenbach, G; Skopnik, H, 1993) |
| " The serum protein binding of theophylline was studied in 28 asthmatics and 11 patients with cystic fibrosis (CF) who were receiving the drug regularly." | 3.68 | Variability of the serum protein binding of theophylline in patients with asthma and cystic fibrosis. ( Blanchard, J; Harvey, S; Morgan, WJ, 1992) |
| "Theophylline levels in stimulated and unstimulated mixed saliva were compared with total and free (unbound) serum theophylline levels in 11 outpatients with cystic fibrosis (CF) who were using theophylline regularly." | 3.68 | Relationship between serum and saliva theophylline levels in patients with cystic fibrosis. ( Blanchard, J; Harvey, S; Morgan, WJ, 1992) |
| "Multiple aspects of lung function were measured in 17 cystic fibrosis (CF) patients on four occasions: without therapy (0); with oral theophylline medication (Th); after inhalation of salbutamol (beta 2); and with combined medication (Th + beta 2)." | 3.67 | Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathomimetics. ( Eber, E; Oberwaldner, B; Zach, MS, 1988) |
| "The elimination of theophylline after intravenous aminophylline bolus and the absorption of a sustained-release oral theophylline preparation (Theo-Dur) were studied in ten patients with cystic fibrosis (C." | 3.66 | Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis. ( Brooks, JG; Schwartz, RH; Valet, SB, 1983) |
| "The disposition of intravenously and orally administered theophylline was compared in 10 patients with cystic fibrosis (CF) and 10 healthy volunteers." | 3.66 | Theophylline disposition in cystic fibrosis. ( Isles, A; Levison, H; MacLeod, S; Spino, M; Tabachnik, E; Thiessen, J, 1983) |
| "Alkaline phosphatase (ALP) activities were compared in fibroblasts from three cystic fibrosis patients and two normal controls after culturing the cells in normal growth medium and in medium containing Tamm-Horsfall glycoprotein, isoproterenol, and theophylline." | 3.66 | Alkaline phosphatase activity of normal and cystic fibrosis fibroblasts. ( Aitken, DA; Hoogeveen, A, 1980) |
| "The specific induction of alkaline phosphatase with Tamm-Horsfall glycoprotein, isoproterenol, and theophylline in skin-derived fibroblast cultures from patients with cystic fibrosis permits one to reliably discriminate between cystic fibrosis patients on the one hand, and heterozygotes and normals on the other." | 3.66 | Reliable detection of cystic fibrosis in skin-derived fibroblast cultures. ( Hösli, P; Vogt, E, 1978) |
| " Although, in patients with CF, the extent of drug absorption varies widely and the rate of absorption is slower, bioavailability is not altered." | 2.40 | Drug disposition in cystic fibrosis. ( Pons, G; Rey, E; Tréluyer, JM, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (52.17) | 18.7374 |
| 1990's | 15 (32.61) | 18.2507 |
| 2000's | 5 (10.87) | 29.6817 |
| 2010's | 2 (4.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, WJ | 1 |
| Goeckeler-Fried, JL | 1 |
| Havasi, V | 1 |
| Chiang, A | 1 |
| Rowe, SM | 1 |
| Plyler, ZE | 1 |
| Hong, JS | 1 |
| Mazur, M | 1 |
| Piazza, GA | 1 |
| Keeton, AB | 1 |
| White, EL | 1 |
| Rasmussen, L | 1 |
| Weissman, AM | 1 |
| Denny, RA | 1 |
| Brodsky, JL | 1 |
| Sorscher, EJ | 1 |
| Goodwin, AT | 1 |
| Singanayagam, A | 1 |
| Jenkins, G | 1 |
| Balfour-Lynn, IM | 2 |
| Elborn, JS | 1 |
| Buckley, SM | 1 |
| Waddington, SN | 1 |
| Jezzard, S | 1 |
| Lawrence, L | 1 |
| Schneider, H | 1 |
| Holder, MV | 1 |
| Themis, M | 1 |
| Coutelle, C | 1 |
| Canny, GJ | 1 |
| de Souza, ME | 1 |
| Gilday, DL | 1 |
| Newth, CJ | 1 |
| Anderson, SD | 1 |
| Bukowskyj, M | 1 |
| Nakatsu, K | 1 |
| Munt, PW | 1 |
| Morgan, WJ | 3 |
| Taussig, LM | 1 |
| Sato, K | 1 |
| Sato, F | 1 |
| Valet, SB | 1 |
| Schwartz, RH | 1 |
| Brooks, JG | 1 |
| Isles, A | 1 |
| Spino, M | 2 |
| Tabachnik, E | 1 |
| Levison, H | 1 |
| Thiessen, J | 1 |
| MacLeod, S | 1 |
| Berger, HJ | 1 |
| Matthay, RA | 1 |
| Götz, M | 1 |
| Georgitis, JW | 1 |
| Eigen, H | 1 |
| Warner, R | 1 |
| Gonzales, MA | 1 |
| Aitken, DA | 1 |
| Hoogeveen, A | 1 |
| Becq, F | 1 |
| Fanjul, M | 1 |
| Merten, M | 1 |
| Figarella, C | 1 |
| Hollande, E | 1 |
| Gola, M | 1 |
| Reisman, JJ | 1 |
| Kusenbach, G | 1 |
| Friedrichs, F | 1 |
| Skopnik, H | 1 |
| Heimann, G | 1 |
| Kearns, GL | 1 |
| Teune, TM | 1 |
| Timmers-Reker, AJ | 1 |
| Bouquet, J | 1 |
| Bijman, J | 1 |
| De Jonge, HR | 1 |
| Sinaasappel, M | 1 |
| Rey, E | 1 |
| Tréluyer, JM | 1 |
| Pons, G | 1 |
| Self, TH | 1 |
| Chafin, CC | 1 |
| Soberman, JE | 1 |
| McPherson, MA | 1 |
| Pereira, MM | 1 |
| Russell, D | 1 |
| McNeilly, CM | 1 |
| Morris, RM | 1 |
| Stratford, FL | 1 |
| Dormer, RL | 1 |
| Hösli, P | 2 |
| Kollberg, H | 1 |
| Vogt, E | 2 |
| Shapiro, GG | 1 |
| Bamman, J | 1 |
| Kanarek, P | 1 |
| Bierman, CW | 1 |
| Blanchard, J | 2 |
| Harvey, S | 2 |
| Sweet, A | 1 |
| Erickson, RP | 1 |
| Huntington, C | 1 |
| Dawson, D | 1 |
| O'Mahony, MS | 1 |
| FitzGerald, MX | 1 |
| Goldstein, JL | 2 |
| Shapiro, AB | 1 |
| Rao, MC | 2 |
| Layden, TJ | 2 |
| Jefferson, DM | 1 |
| Valentich, JD | 1 |
| Marini, FC | 1 |
| Grubman, SA | 1 |
| Iannuzzi, MC | 1 |
| Dorkin, HL | 1 |
| Li, M | 1 |
| Klinger, KW | 1 |
| Welsh, MJ | 1 |
| Avital, A | 1 |
| Sanchez, I | 1 |
| Holbrow, J | 1 |
| Kryger, M | 1 |
| Chernick, V | 1 |
| Taylor, DM | 1 |
| Flowers, MK | 1 |
| Squassoni, E | 1 |
| Cabrini, G | 1 |
| Berton, G | 1 |
| Suter, S | 1 |
| Chevallier, I | 1 |
| Krause, KH | 1 |
| Lew, DP | 1 |
| Pan, SH | 1 |
| Canafax, DM | 1 |
| Le, CT | 1 |
| Cipolle, RJ | 1 |
| Uden, DL | 1 |
| Warwick, WJ | 1 |
| Pedersen, SS | 1 |
| Berschneider, HM | 1 |
| Knowles, MR | 1 |
| Azizkhan, RG | 1 |
| Boucher, RC | 1 |
| Tobey, NA | 1 |
| Orlando, RC | 1 |
| Powell, DW | 1 |
| Storm, W | 1 |
| Knoppert, DC | 1 |
| Beck, R | 1 |
| Thiessen, JJ | 1 |
| MacLeod, SM | 1 |
| Nash, NT | 1 |
| al-Bazzaz, F | 1 |
| Eber, E | 1 |
| Oberwaldner, B | 1 |
| Zach, MS | 1 |
| Mangos, JA | 1 |
| Benke, PJ | 1 |
| McSherry, N | 1 |
| Richards, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00005279] | 0 participants | Observational | 1971-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for theophylline and Cystic Fibrosis
| Article | Year |
|---|---|
"CF asthma": what is it and what do we do about it?
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Asthma; Bronchial Hyperreactivity; Bronchodila | 2002 |
Asthma in cystic fibrosis.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Asthma; Bronchodilator Agents; Chi | 2003 |
Drugs affecting the respiratory system with particular reference to asthma.
Topics: Adrenergic alpha-Antagonists; Asthma; Asthma, Exercise-Induced; Bronchi; Child; Cromolyn Sodium; Cys | 1981 |
Theophylline reassessed.
Topics: Acidosis; Aging; Allopurinol; Animals; Anti-Bacterial Agents; Breast Feeding; Bronchodilator Agents; | 1984 |
The chronic bronchitis complex in children.
Topics: Adrenergic beta-Agonists; Adult; Age Factors; Air Pollution; Anti-Bacterial Agents; Asthma; Bronchit | 1984 |
Noninvasive radiographic assessment of cardiovascular function in acute and chronic respiratory failure.
Topics: Acute Disease; Aminophylline; Blood Pressure; Cardiovascular System; Chronic Disease; Cystic Fibrosi | 1981 |
Advances in respiratory therapeutics in children.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Anti-Inflammatory Agents; Asthma; Bronchiolitis, | 1993 |
Hepatic drug metabolism in cystic fibrosis: recent developments and future directions.
Topics: Bile; Biotransformation; Child; Child, Preschool; Cystic Fibrosis; Fleroxacin; Humans; Liver; Liver | 1993 |
Drug disposition in cystic fibrosis.
Topics: Absorption; Anti-Infective Agents; Ciprofloxacin; Cloxacillin; Cyclosporine; Cystic Fibrosis; Flerox | 1998 |
Effect of disease states on theophylline serum concentrations: are we still vigilant?
Topics: Cystic Fibrosis; Fever; Heart Failure; Humans; Liver Cirrhosis; Pulmonary Heart Disease; Theophyllin | 2000 |
Clinical efficacy of ciprofloxacin in lower respiratory tract infections.
Topics: Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Drug Interactions; Humans; Lung Diseases, | 1989 |
Differential diagnosis of childhood asthma.
Topics: Age Factors; Asthma; Child; Child Health Services; Child, Institutionalized; Cystic Fibrosis; Defici | 1974 |
7 trials available for theophylline and Cystic Fibrosis
| Article | Year |
|---|---|
Radionuclide assessment of cardiac performance in cystic fibrosis. Reproducibility and effect of theophylline on cardiac function.
Topics: Adolescent; Adult; Aminophylline; Cardiac Output; Cystic Fibrosis; Erythrocytes; Female; Heart; Huma | 1984 |
Reliable diagnosis of the major type of cystic fibrosis with fibroblast cultures. A double blind study.
Topics: Adolescent; Adult; Alkaline Phosphatase; Cells, Cultured; Child; Child, Preschool; Clinical Trials a | 1978 |
The paradoxical effect of adrenergic and methylxanthine drugs in cystic fibrosis.
Topics: Administration, Oral; Adolescent; Adult; Aerosols; Child; Clinical Trials as Topic; Cystic Fibrosis; | 1976 |
Effect of theophylline on lung function tests, sleep quality, and nighttime SaO2 in children with cystic fibrosis.
Topics: Child; Cystic Fibrosis; Double-Blind Method; Female; Heart Rate; Humans; Male; Monitoring, Physiolog | 1991 |
Bronchodilation from intravenous theophylline in patients with cystic fibrosis: results of a blinded placebo-controlled crossover clinical trial.
Topics: Adolescent; Adult; Bronchi; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; F | 1989 |
Clinical efficacy of ciprofloxacin in lower respiratory tract infections.
Topics: Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Drug Interactions; Humans; Lung Diseases, | 1989 |
Cystic fibrosis: enhanced theophylline metabolism may be linked to the disease.
Topics: Adolescent; Adult; Biotransformation; Chromatography, High Pressure Liquid; Clinical Trials as Topic | 1988 |
28 other studies available for theophylline and Cystic Fibrosis
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regu | 2016 |
Review of the British Thoracic Society Winter Meeting 2018, 5-7 December 2018, London, UK.
Topics: Asthma; Bronchodilator Agents; Cystic Fibrosis; Drug Resistance, Microbial; Genetic Therapy; Humans; | 2019 |
Factors influencing adenovirus-mediated airway transduction in fetal mice.
Topics: Adenosine; Adenoviridae; Animals; Carbon; Carbon Dioxide; Colloids; Cystic Fibrosis; Enzyme-Linked I | 2005 |
Defective beta adrenergic response of cystic fibrosis sweat glands in vivo and in vitro.
Topics: Atropine; Child; Cystic Fibrosis; Humans; Isoproterenol; Methacholine Chloride; Methacholine Compoun | 1984 |
Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
Topics: Adolescent; Adult; Biological Availability; Child; Cystic Fibrosis; Delayed-Action Preparations; Die | 1983 |
Theophylline disposition in cystic fibrosis.
Topics: Administration, Oral; Adolescent; Adult; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; | 1983 |
[Obstructive airway diseases in children].
Topics: Abscess; Adult; Asthma; Child; Child, Preschool; Cystic Fibrosis; Foreign-Body Reaction; Humans; Inh | 1982 |
Oral theophylline disposition in cystic fibrosis.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Cystic Fibrosis; Female; Half-Life; Human | 1982 |
Alkaline phosphatase activity of normal and cystic fibrosis fibroblasts.
Topics: Alkaline Phosphatase; Cells, Cultured; Child; Cystic Fibrosis; Female; Glycoproteins; Humans; Isopro | 1980 |
Possible regulation of CFTR-chloride channels by membrane-bound phosphatases in pancreatic duct cells.
Topics: 1-Methyl-3-isobutylxanthine; Alkaline Phosphatase; Base Sequence; Chloride Channels; Chlorides; Cyst | 1993 |
Increased physiological dead space during exercise after bronchodilation in cystic fibrosis.
Topics: Adolescent; Airway Resistance; Albuterol; Bronchi; Cystic Fibrosis; Female; Humans; Male; Physical E | 1993 |
In vivo measurement of chloride and water secretion in the jejunum of cystic fibrosis patients.
Topics: Adolescent; Adult; Bicarbonates; Body Water; Catheterization; Chlorides; Cystic Fibrosis; Electrophy | 1996 |
The CFTR-mediated protein secretion defect: pharmacological correction.
Topics: Adrenergic beta-Agonists; Animals; Cell Line; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmemb | 2001 |
Reliable detection of cystic fibrosis in skin-derived fibroblast cultures.
Topics: Alkaline Phosphatase; Cells, Cultured; Cystic Fibrosis; Enzyme Induction; Female; Fibroblasts; Glyco | 1978 |
Variability of the serum protein binding of theophylline in patients with asthma and cystic fibrosis.
Topics: Adolescent; Adult; Aged; Asthma; Blood Proteins; Chromatography, High Pressure Liquid; Cystic Fibros | 1992 |
Relationship between serum and saliva theophylline levels in patients with cystic fibrosis.
Topics: Adolescent; Adult; Asthma; Child; Cystic Fibrosis; Humans; Lung Diseases; Regression Analysis; Saliv | 1992 |
A potential animal model for studying CF heterozygote advantage: genetic variation in theophylline-inducible colonic chloride currents among inbred strains of mice.
Topics: Animals; Chlorides; Colon; Cystic Fibrosis; Disease Models, Animal; Electric Conductivity; Female; G | 1992 |
Cystic fibrosis and seizures.
Topics: Adult; Ciprofloxacin; Cystic Fibrosis; Humans; Seizures; Theophylline | 1991 |
In vivo evidence of altered chloride but not potassium secretion in cystic fibrosis rectal mucosa.
Topics: Adult; Bethanechol; Bethanechol Compounds; Biological Transport, Active; Calcium; Chlorides; Cyclic | 1991 |
Expression of normal and cystic fibrosis phenotypes by continuous airway epithelial cell lines.
Topics: Antigens, Polyomavirus Transforming; Base Sequence; Biomarkers; Blood Proteins; Bradykinin; Calcimyc | 1990 |
Variable theophylline clearance in cystic fibrosis.
Topics: Adult; Ciprofloxacin; Cystic Fibrosis; Drug Interactions; Humans; Male; Metabolic Clearance Rate; Th | 1991 |
cAMP dependent chloride conductance is not different in cystic fibrosis fibroblasts.
Topics: Alprostadil; Biological Transport, Active; Bucladesine; Cell Line; Chlorides; Cyclic AMP; Cystic Fib | 1990 |
Effect of cyclic adenosine monophosphate elevations on functional responses of polymorphonuclear leukocytes from patients with cystic fibrosis.
Topics: Adolescent; Adult; Child; Child, Preschool; Colforsin; Cyclic AMP; Cystic Fibrosis; Cytoplasmic Gran | 1989 |
Altered intestinal chloride transport in cystic fibrosis.
Topics: Adult; Amiloride; Biological Transport; Calcimycin; Chlorides; Cyclic AMP; Cystic Fibrosis; Electric | 1988 |
[Respiratory insufficiency in mucoviscidosis. Pathophysiologic aspects of conservative drug therapy].
Topics: Acid-Base Equilibrium; Child; Combined Modality Therapy; Cystic Fibrosis; Drug Therapy, Combination; | 1989 |
Rectum has abnormal ion transport but normal cAMP-binding proteins in cystic fibrosis.
Topics: Adult; Amiloride; Biological Transport, Active; Carrier Proteins; Chlorides; Cyclic AMP Receptor Pro | 1988 |
Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathomimetics.
Topics: Adolescent; Adult; Airway Obstruction; Albuterol; Child; Cystic Fibrosis; Drug Therapy, Combination; | 1988 |
Salivary gland enlargement and functional changes during feeding of pancreatin to rats. (Possible relation to functional changes in cystic fibrosis).
Topics: Animals; Cyclic AMP; Cystic Fibrosis; Male; Organ Size; Pancreatin; Parotid Gland; Rats; Saliva; Sal | 1969 |